Trial to Evaluate the Efficacy and Safety of Substrate Ablation of Monomorphic Ventricular Tachycardia
Status:
Completed
Trial end date:
2017-09-30
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of substrate-based radiofrequency catheter ablation vs.
antiarrhythmic drug therapy in patients with ischemic cardiomyopathy and scar-related
sustained monomorphic ventricular tachycardia.